维普中文期刊产品整合服务
32篇 您的检索式:作者名="Raverot"
    题名 作者 年代 出处 被引量
1Mitolane has an estrogenic effect on sex hornnme-binding globulin and cnrtieosternid-binding globulin in humans 显示文摘Nader N Raverot ( Emptoz-Bonnelon A el al 2006J Clia Endocrinnl Metab2006,91,:1
2Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development 显示文摘Park S Y Meeks J J Raverot G 2005Development2005,132,10:1
3Pregnant French women living in the Lyon area are iodine deficient and have elevated serum thyroglobulin concentrations显示文摘Raverot V 2012Thyroid2012,22,5:1
4Pituitary carcinomas and aggressive pituitary tumors: merits and pitfalls of temozolo- mide treatment显示文摘Raverot G Castinetti F Jouanneau E 2012Clin Endoerinol2012,76,6:1
5Predicting vis-ual outcome after treatment of pituitary adenoma withoptical coherence tomography 显示文摘Jacob M Raverot G Jouanneau E 2009Am J ophthalmolo-gy2009,147,:1
6Prognostic factors in prolactin pituitary tumors : clinical,histological,and molecular data from a series of 94 patients with a long postoperative follow-up显示文摘RAVEROT G WIERINCKX A DANTONY E 2010JCEM2010,95,4:1
7Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas : a French muhicenter experience 显示文摘Raverot G Sturm N de Fraipont F 2010J Clin Endocrinol Metab2010,95,10:1
8Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal 显示文摘Messerer M De Battista JC Raverot G 2011Neurosurg Focus2011,30,4:1
9Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience显示文摘Raverot G Sturm N de Fraipont F 2010J Clin Endocrinol Metab2010,95,10:1
10Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment 显示文摘Raverot G Castinetti F Jouanneau E 2012Clin Endocrinol (Oxf)2012,76,6:1
11Temozolomide treatmentin aggressive pituitary tumors and pituitary carcinomas:a Frenchmulticenter experience显示文摘Raverot G Sturm N de Fraipont F 0,,10:1
12Giant prolactinomas in women显示文摘OBJECTIVE:To characterise distinctive clinical features of giant prolactinomas in women.DESIGN:A multicentre,retrospective case series and literature review.METHODS:We collected data from 15 female patients with a pituitary turnout larger than 4 cm and prolactin levels above 1000μg/l and identified 19 similar cases from the literature;a gender-based comparison of the frequency and age distribution was obtained from a literature review.RESULTS:The initial PubMed search using the term giant prolactinomas'identified 125 patients(13 women)responding to the inclusion criteria.The female:male ratio was 1:9.Another six female patients were found by extending the literature search,while our own series added 15 patients.The median age at diagnosis was 44 yearsDelgrange E Raverot G Bex M Burman P Decoudier B Devuyst F Feldt-Rasmussen U Andersen M Maiter D 2013中国神经肿瘤杂志2013,11,4:1
13Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas:a French multicenter experience显示文摘Raverot G Sturm N de-Fraipont F 0,,10:1
14Prognostic factors in prolaetin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up 显示文摘Raverot G Wierinckx A Dantony E 2010J Clin Endoerinol Metab2010,95,4:1
15Hypothalamo-pituitary sarcoidosis:a multicenter study of 24 patients显示文摘Langrand C Bihan H Raverot G 2012QJM2012,105,10:1
16Sox3 expression in undifferentiated spermatogonia is required for the progression of spermatogenesis显示文摘Raverot G Weiss J Park SY 2005Dev Biol2005,283,1:1
17Temozolomide treatment in aggressive pituitary tumors and pituitary carcino- mas: a French multicenter experience显示文摘Raverot G Sturm N de Fraipont F 2010J Clin Endoerinol Metab2010,95,10:1
18Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up 显示文摘Raverot G Wierinckx A Dantony E 2010Journal of Clinical Endocrinology and Metabolism2010,95,4:1
19Evidence of improvedsurgical outcome following endoscopy for nonfunctioning pituitary adenoma removal显示文摘Messerer M De Battista JC Raverot G 2011Neurosurg Focus2011,30,:1
20Pituitary carcinomas and aggressive pituitary turnouts : merits and pitfalls of temozolomide treatment显示文摘Raverot G Castinetti F Jouanneau E 2012Clin Endocrinol(Oxf)2012,76,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费